- Home
- OKYO vs SPAI Comparison
OKYO vs SPAI Comparison
Compare OKYO & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | SPAI |
|---|---|---|
| Founded | 2007 | 2021 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.4M | 87.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | OKYO | SPAI |
|---|---|---|
| Price | $1.60 | $4.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.33 | ★ $10.00 |
| AVG Volume (30 Days) | 91.6K | ★ 192.3K |
| Earning Date | 07-18-2025 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,060.58 |
| Revenue Next Year | N/A | $162.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $2.47 |
| 52 Week High | $3.35 | $9.16 |
Technical Indicators
Market Signals| Indicator | OKYO | SPAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 50.92 |
| Support Level | $1.50 | $3.81 |
| Resistance Level | $1.73 | $4.89 |
| Average True Range (ATR) | 0.12 | 0.38 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 68.00 | 66.72 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About SPAI Safe Pro Group Inc.
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.